Oncology CME

• Liver Metastases From Colorectal Cancer: Radioembolization With Systemic Therapy CME Radioembolization is a treatment option for patients with metastatic CRC, but physicians need to recognize potential contraindications and complications associated with this treatment.
  Nature Reviews Clinical Oncology, December 2009
• Statins May Reduce Cancer Deaths in COPD Patients: Study CME In a Dutch study, treatment with statins in patients with chronic obstructive pulmonary disease was associated with a reduced mortality risk from extrapulmonary cancer.
  Reuters Health Information CME, November 2009
• Pap Tests and Liquid-Based Cytology Equivalent in Detecting Precancerous Lesions CME A large Dutch study reports that liquid-based cytology was neither more sensitive nor more specific than conventional Pap tests in detecting precancerous lesions or cervical cancer.
  Medscape Medical News CME, November 2009
• FDA Approvals: Arzerra and Berinert CME/CE The FDA has granted accelerated approval of ofatumumab intravenous infusion for chronic lymphocytic leukemia and has also approved an intravenous therapy for hereditary angioedema.
  Medscape Medical News CME, November 2009
• Setting a Course Toward Prostate Cancer Prevention: Communicating the Evidence to Our Patients CME Evaluate the differences, strengths, and limitations of current prostate cancer screening tests and review prevention strategies, including chemoprevention with pharmacologic agents.
  November 2009
• Risk Stratification in Hematologic Malignancies   CME/CE Drs. Kanti R. Rai and Steven E. Coutre address the latest risk stratification strategies for patients with a variety of hematologic malignancies.
  MedscapeCME Oncology, November 2009
• Depression in Older Cancer Patients Responds Better to Collaborative Program CME A collaborative program headed by a depression care manager, which included a structured psychotherapy program, was better than usual care in older cancer patients with depression.
  Medscape Medical News CME, November 2009
• Serum Free Light Chain Assessment in Monoclonal Gammopathy and Kidney Disease CME New laboratory assessments may provide increased information and better management of disease related to free light chains. The current review describes these illnesses and their assessment.
  Nature Reviews Nephrology, November 2009
• Diagnosis of Insulinoma in a Patient With Hypoglycemia Without Obvious Hyperinsulinemia CME Guidelines for the diagnosis of insulinoma suggest a threshold of over 3.0 or 6.0 mLU/L for plasma insulin in the presence of documented hypoglycemia, but exceptions may occur.
  Nature Reviews Endocrinology, November 2009
• Refractory Neuroendocrine Tumor -- Response to Liposomal Doxorubicin and Capecitabine CME Carcinoid tumors may be associated with specific symptoms and require treatment which differs from that of other tumors. This case and review describe the diagnosis and management of carcinoid tumors.
  Nature Reviews Clinical Oncology, November 2009
• A Reappraisal of the Significance of Largest Basal Diameter of Posterior Uveal Melanoma Largest tumor diameter is the most widely used predictor of metastatic disease in patients with uveal melanoma, but genomic studies suggest that histologic and cytogenetic factors play an important role as well.
  Eye, November 2009
• Updates on Uterine Papillary Serous Carcinoma CME UPSC is an aggressive endometrial carcinoma that has been said to behave more like an ovarian carcinoma, but recent advances in treatment have added targeted chemotherapy to the armamentarium of options to improve outcomes.
  Expert Review of Obstetrics & Gynecology, November 2009
• Pharmacoeconomic Considerations Associated With Use of Oral Agents in Metastatic Breast Cancer CME In this Expert Column, Dr. Hope S. Rugo evaluates the cost-effectiveness of oral therapies for breast cancer.
  MedscapeCME Oncology, October 2009
• Patients With IBD at Risk of Developing Nonmelanoma Skin Cancer CME Immunosuppressant therapy for inflammatory bowel disease (IBD) is associated with an increased risk for nonmelanoma skin cancer.
  Medscape Medical News CME, October 2009
• Oral Breast Cancer Therapies: Issues With Adherence CME Drs. Ann Partridge and Kathryn Ruddy explore the advantages and disadvantages of oral therapies in the treatment of breast cancer.
  MedscapeCME Oncology, October 2009
• FDA Approvals: Elitek, Fluarix, Votrient CME/CE The FDA has approved an expanded indication for rasburicase intravenous infusion, a pediatric use of a trivalent inactivated influenza vaccine, and pazopanib tablets for advanced renal cell carcinoma.
  Medscape Medical News CME, October 2009
• Thiopurine Treatment of Inflammatory Bowel Disease Linked to Risk for Lymphoproliferative Disorders CME In a prospective observational cohort study, patients receiving thiopurines for inflammatory bowel disease had an increased risk for the development of lymphoproliferative disorders.
  Medscape Medical News CME, October 2009
• Bladder Cancer Management Reviewed CME A review for primary care clinicians suggests best practices for the diagnosis and treatment of bladder cancer.
  Medscape Medical News CME, October 2009
• Chronic Lymphocytic Leukemia: Improving the Odds With Monoclonal Antibody Therapy CME Drs. Constantine Tam and Michael Keating examine the role of chemoimmunotherapy in chronic lymphocytic leukemia.
  MedscapeCME Oncology, October 2009
• New-Onset Breast Tenderness During Hormone Therapy Linked to Increased Breast Cancer Risk CME/CE In a randomized controlled trial, new-onset breast tenderness during conjugated equine estrogens plus medroxyprogesterone therapy was associated with increased breast cancer risk.
  Medscape Medical News CME, October 2009